Cancer Biology & Medicine(2022年07期)
癌症生物学与医学(英文版)

目 录

• Rosiglitazone disrupts pancreatic ductal adenocarcinoma progression by activating the tumor suppressor ESE3/EHF
• Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies
• Living biobank-based cancer organoids: prospects and challenges in cancer research
• ANTP-SMACN7 fusion peptide alone induced high linear energy transfer irradiation radiosensitization in non-small cell lung cancer cell lines
• SY-1530, a highly selective BTK inhibitor, effectively treats B-cell malignancies by blocking B-cell activation
• IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
• Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
• Dual-targeted lung cancer therapy via inhalation delivery of UCNP-siRNA-AS1411 nanocages
• Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
• Microwave ablation vs. surgical resection for treatment na?ve hepatocellular carcinoma within the Milan criteria: a follow-up of at least 5 years
• Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma:a prospective phase Ⅱ trial
• Feasibility of sentinel lymph node biopsy omission after integration of u003csupu003e18u003c/supu003eF-FDG dedicated lymph node PET in early breast cancer:a prospective phase Ⅱ trial